Back to search

Article

Gastrointestinal Symptoms in Pediatric Patients with Anxiety Disorders and their Relationship to Treatment with Escitalopram or Placebo

2023-04-05

Abstract excerpt

Gastrointestinal symptoms are commonly reported as adverse effects of selective serotonin reuptake inhibitors (SSRIs), the first-line pharmacologic treatment for pediatric anxiety disorders; however, the temporal course of these symptoms during treatment, although believed to be transient, has never been prospectively evaluated. Additionally, rates of gastrointestinal symptoms and functional gastrointestinal syndr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d32c9135-fc9d-52ff-8082-380992e462f8
DOI
10.21203/rs.3.rs-2762240/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Gastrointestinal Symptoms in Pediatric Patients with Anxiety Disorders and their Relationship to Treatment with Escitalopram or PlaceboDOI 10.21203/rs.3.rs-2762240/v1
Select a neighboring publication to make it the new centre.